Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity

Several arenaviruses cause hemorrhagic fever (HF) disease in humans and represent important public health problems in their endemic regions. In addition, evidence indicates that the worldwide-distributed prototypic arenavirus lymphocytic choriomeningitis virus is a neglected human pathogen of clinical significance. There are no licensed arenavirus vaccines, and current antiarenavirus therapy is limited to an off-label use of ribavirin that is only partially effective. Therefore, there is an unmet need for novel therapeutics to combat human pathogenic arenaviruses, a task that will be facilitated by the identification of compounds with antiarenaviral activity that could serve as probes to identify arenavirus-host interactions suitable for targeting, as well as lead compounds to develop future antiarenaviral drugs. Screening of a combinatorial library of Krönhke pyridines identified compound KP-146 [(5-(5-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)-4′-methoxy-[1,1′-biphenyl]-3-yl)thiophene-2-carboxamide] as having strong anti-lymphocytic choriomeningitis virus (LCMV) activity in cultured cells. KP-146 did not inhibit LCMV cell entry but rather interfered with the activity of the LCMV ribonucleoprotein (vRNP) responsible for directing virus RNA replication and gene transcription, as well as with the budding process mediated by the LCMV matrix Z protein. LCMV variants with increased resistance to KP-146 did not emerge after serial passages in the presence of KP-146. Our findings support the consideration of Kröhnke pyridine scaffold as a valuable source to identify compounds that could serve as tools to dissect arenavirus-host interactions, as well as lead candidate structures to develop antiarenaviral drugs.

Saved in:
Bibliographic Details
Main Authors: Miranda, Pedro O., Cubitt, Beatrice, Jacob, Nicholas T., Janda, Kim D., De La Torre, Juan C.
Other Authors: National Institutes of Health (US)
Format: artículo biblioteca
Published: ACS Publications 2018-02-06
Subjects:Arenavirus, Protein−protein interaction, Anti-LCMV activity, Kröhnke pyridine library,
Online Access:http://hdl.handle.net/10261/183315
http://dx.doi.org/10.13039/100000002
http://dx.doi.org/10.13039/501100000780
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-ipna-es-10261-183315
record_format koha
spelling dig-ipna-es-10261-1833152020-12-10T16:14:28Z Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity Miranda, Pedro O. Cubitt, Beatrice Jacob, Nicholas T. Janda, Kim D. De La Torre, Juan C. National Institutes of Health (US) European Commission Arenavirus Protein−protein interaction Anti-LCMV activity Kröhnke pyridine library Several arenaviruses cause hemorrhagic fever (HF) disease in humans and represent important public health problems in their endemic regions. In addition, evidence indicates that the worldwide-distributed prototypic arenavirus lymphocytic choriomeningitis virus is a neglected human pathogen of clinical significance. There are no licensed arenavirus vaccines, and current antiarenavirus therapy is limited to an off-label use of ribavirin that is only partially effective. Therefore, there is an unmet need for novel therapeutics to combat human pathogenic arenaviruses, a task that will be facilitated by the identification of compounds with antiarenaviral activity that could serve as probes to identify arenavirus-host interactions suitable for targeting, as well as lead compounds to develop future antiarenaviral drugs. Screening of a combinatorial library of Krönhke pyridines identified compound KP-146 [(5-(5-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)-4′-methoxy-[1,1′-biphenyl]-3-yl)thiophene-2-carboxamide] as having strong anti-lymphocytic choriomeningitis virus (LCMV) activity in cultured cells. KP-146 did not inhibit LCMV cell entry but rather interfered with the activity of the LCMV ribonucleoprotein (vRNP) responsible for directing virus RNA replication and gene transcription, as well as with the budding process mediated by the LCMV matrix Z protein. LCMV variants with increased resistance to KP-146 did not emerge after serial passages in the presence of KP-146. Our findings support the consideration of Kröhnke pyridine scaffold as a valuable source to identify compounds that could serve as tools to dissect arenavirus-host interactions, as well as lead candidate structures to develop antiarenaviral drugs. This research was supported by NIH/NIAID grants AI047140 and AI077719 to J.C.d.l.T. P.O.M. was supported by a fellowship from the European Union’s Seventh Framework Program FP7/2007-2013 under REA Grant Agreement No.623155. Peer Reviewed 2019-06-04T14:57:02Z 2019-06-04T14:57:02Z 2018-02-06 2019-06-04T14:57:02Z artículo http://purl.org/coar/resource_type/c_6501 doi: 10.1021/acsinfecdis.7b00236 e-issn: 2373-8227 ACS Infectious Diseases 4(5): 815-824 (2018) http://hdl.handle.net/10261/183315 10.1021/acsinfecdis.7b00236 http://dx.doi.org/10.13039/100000002 http://dx.doi.org/10.13039/501100000780 #PLACEHOLDER_PARENT_METADATA_VALUE# info:eu-repo/grantAgreement/EC/FP7/623155 Postprint https://doi.org/10.1021/acsinfecdis.7b00236 Sí none ACS Publications
institution IPNA ES
collection DSpace
country España
countrycode ES
component Bibliográfico
access En linea
databasecode dig-ipna-es
tag biblioteca
region Europa del Sur
libraryname Biblioteca del IPNA España
topic Arenavirus
Protein−protein interaction
Anti-LCMV activity
Kröhnke pyridine library
Arenavirus
Protein−protein interaction
Anti-LCMV activity
Kröhnke pyridine library
spellingShingle Arenavirus
Protein−protein interaction
Anti-LCMV activity
Kröhnke pyridine library
Arenavirus
Protein−protein interaction
Anti-LCMV activity
Kröhnke pyridine library
Miranda, Pedro O.
Cubitt, Beatrice
Jacob, Nicholas T.
Janda, Kim D.
De La Torre, Juan C.
Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity
description Several arenaviruses cause hemorrhagic fever (HF) disease in humans and represent important public health problems in their endemic regions. In addition, evidence indicates that the worldwide-distributed prototypic arenavirus lymphocytic choriomeningitis virus is a neglected human pathogen of clinical significance. There are no licensed arenavirus vaccines, and current antiarenavirus therapy is limited to an off-label use of ribavirin that is only partially effective. Therefore, there is an unmet need for novel therapeutics to combat human pathogenic arenaviruses, a task that will be facilitated by the identification of compounds with antiarenaviral activity that could serve as probes to identify arenavirus-host interactions suitable for targeting, as well as lead compounds to develop future antiarenaviral drugs. Screening of a combinatorial library of Krönhke pyridines identified compound KP-146 [(5-(5-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)-4′-methoxy-[1,1′-biphenyl]-3-yl)thiophene-2-carboxamide] as having strong anti-lymphocytic choriomeningitis virus (LCMV) activity in cultured cells. KP-146 did not inhibit LCMV cell entry but rather interfered with the activity of the LCMV ribonucleoprotein (vRNP) responsible for directing virus RNA replication and gene transcription, as well as with the budding process mediated by the LCMV matrix Z protein. LCMV variants with increased resistance to KP-146 did not emerge after serial passages in the presence of KP-146. Our findings support the consideration of Kröhnke pyridine scaffold as a valuable source to identify compounds that could serve as tools to dissect arenavirus-host interactions, as well as lead candidate structures to develop antiarenaviral drugs.
author2 National Institutes of Health (US)
author_facet National Institutes of Health (US)
Miranda, Pedro O.
Cubitt, Beatrice
Jacob, Nicholas T.
Janda, Kim D.
De La Torre, Juan C.
format artículo
topic_facet Arenavirus
Protein−protein interaction
Anti-LCMV activity
Kröhnke pyridine library
author Miranda, Pedro O.
Cubitt, Beatrice
Jacob, Nicholas T.
Janda, Kim D.
De La Torre, Juan C.
author_sort Miranda, Pedro O.
title Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity
title_short Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity
title_full Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity
title_fullStr Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity
title_full_unstemmed Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity
title_sort mining a kröhnke pyridine library for anti-arenavirus activity
publisher ACS Publications
publishDate 2018-02-06
url http://hdl.handle.net/10261/183315
http://dx.doi.org/10.13039/100000002
http://dx.doi.org/10.13039/501100000780
work_keys_str_mv AT mirandapedroo miningakrohnkepyridinelibraryforantiarenavirusactivity
AT cubittbeatrice miningakrohnkepyridinelibraryforantiarenavirusactivity
AT jacobnicholast miningakrohnkepyridinelibraryforantiarenavirusactivity
AT jandakimd miningakrohnkepyridinelibraryforantiarenavirusactivity
AT delatorrejuanc miningakrohnkepyridinelibraryforantiarenavirusactivity
_version_ 1777669784593235968